GBM cells, typically, also exert the direct suppression of adaptive immunity through the minimal expression of neoantigens and the overexpression of numerous immune checkpoint molecules such as PD-L1 or cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) [37]. This evidence concerns the gene CTLA4 and glioblastoma.